Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

IsraelRecruitingPHASE3

Conditions

Polycythemia Vera

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

  • Emad Ibrahim, MD, Inc, Redlands, California, United States

  • US Oncology Inc, Englewood, Colorado, United States

  • American Oncology Partners of Maryland, PA, Bethesda, Maryland, United States

    Contact: Study coordinator (Victor Priego)
  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

  • The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Oncology Associates of Oregon, P.C., Eugene, Oregon, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

  • Texas Oncology (Webster) - USOR, Houston, Texas, United States

  • Texas Oncology-Denison Cancer Center, Sherman, Texas, United States

    Contact: Principal Investigator (Amir Faridi)
  • University of Utah - Huntsman Cancer Institute - PPDS, Salt Lake City, Utah, United States

  • The James Cancer Hospital and Solove Research Institute, Roanoke, Virginia, United States

  • VA Puget Sound Health Care System - NAVREF - PPDS, Seattle, Washington, United States

  • Landesklinikum Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria

  • Medizinische Universitat Wien (Medical University of Vienna), Vienna, State of Vienna, Austria

  • Ordensklinikum Linz GmbH Elisabethinen, Linz, Upper Austria, Austria

  • Klinikum Wels-Grieskirchen GmbH, Wels, Upper Austria, Austria

  • Acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda, Sofia, Sofia-Grad, Bulgaria

  • University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv, Bulgaria

  • University Multiprofile Hospital for Active Treatment - Prof. Dr. Stoyan Kirkovich AD, Stara Zagora, Bulgaria

  • Clinical Hospital Dubrava, Zagreb, City of Zagreb, Croatia

  • Clinical Hospital Center Rijeka - PPDS, Rijeka, Croatia

  • Clinical Hospital Center Rijeka, Rijeka, Croatia

  • General Hospital Sibenik, Šibenik, Croatia

  • Centre Hospitalier de Saint-Quentin, Saint-Quentin, Aisne, France

  • CHU de Nice, Nice, Alpes-Maritimes, France

  • Centre Hospitalier de Troyes, Troyes, Aube, France

  • Hôpital Bretonneau, Tours, Indre-et-Loire, France

  • CHU Nantes, Nantes, Loire-Atlantique, France

  • CHU Angers, Angers, Maine-et-Loire, France

  • CHU Amiens Hôpital Sud, Amiens, Somme, France

  • Hôpital Saint Louis, Paris, France

  • Hopital d'Argenteuil, Argenteuil, Île-de-France Region, France

  • Medizinische Fakultät Mannheim der Universität Heidelberg, Universitätsmedizin Mannheim, Mannheim, Baden-Wurttemberg, Germany

  • Gemeinschaftspraxis Hämatologie - Onkologie, Dresden, Saxony, Germany

  • Universitätsmedizin Halle, Universitätsklinikum Halle, Klinik für Innere Medizin IV, Halle, Saxony-Anhalt, Germany

  • OncoResearch Lerchenfeld GmbH, Hamburg, Germany

  • Gyor-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház, Győr, Győr-Moson-Sopron, Hungary

  • Szabolcs-Szatmár-Bereg Vármegyei Oktatókórház, Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

  • Tolna Vármegyei Megyei Balassa János Kórház, Szekszárd, Tolna County, Hungary

  • Cork University Hospital, Cork, Ireland

  • Connolly Hospital Blanchardstown, Dublin, Ireland

  • Mater Misericordiae University Hospital, Dublin, Ireland

  • Hadassah Medical Center - PPDS, Jerusalem, Jerusalem, Israel

  • Assuta Medical Center, Tel Aviv, Tel Aviv, Israel

  • Bnai Zion Medical Center, Haifa, Israel

  • Carmel Medical Center, Haifa, Israel

  • Istituto Tumori "Giovanni Paolo II" I.R.C.C.S., Bari, Apulia, Italy

    Contact: Principal Investigator (Paolo Ditonno)
  • Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Calabria, Italy

  • Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico, Bologna, Emilia-Romagna, Italy

  • Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l, Meldola, Emilia-Romagna, Italy

  • Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy

  • Azienda Sanitaria Universitaria Friuli Centrale, Udine, Friuli Venezia Giulia, Italy

  • Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Lazio, Italy

  • Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Lombardy, Italy

    Contact: Study coordinator (Federico Lussana)
  • Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Lombardy, Italy

  • Azienda Sanitaria Ospedaliera S. Croce e Carle, Cuneo, Piedmont, Italy

  • A.O.U. Maggiore della Carità, Novara, Piedmont, Italy

  • Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Piedmont, Italy

  • Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco di Catania, Catania, Sicily, Italy

  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Sicily, Italy

  • Azienda Ospedaliero Universitaria delle Marche, Ancona, The Marches, Italy

  • Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, Italy

  • Spaarne Gasthuis, Hoofddorp, North Holland, Netherlands

  • Medisch Spectrum Twente, Enschede, Overijssel, Netherlands

  • Albert Schweitzer Ziekenhuis, Dordrecht, South Holland, Netherlands

  • Indywidualna Specjalistyczna Praktyka Lekarska Tomasz Woźny, Poznan, Poland

  • Specjalistyczny Szpital im. dra Alfreda Sokołowskiego, Wałbrzych, Poland

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza- Radeckiego we Wrocławiu, Wroclaw, Poland

  • Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia

  • Clinical Hospital Center Zemun, Belgrade, Serbia

  • University Clinical Center of Serbia, Belgrade, Serbia

  • University Clinical Center Nis, Niš, Serbia

  • Clinical Center of Vojvodina, Novi Sad, Serbia

  • ICO Badalona-H.U. Germans Trias i Pujol, Badalona, Barcelona, Spain

  • Hospital General Universitario Dr. Balmis, Alicante, Spain

  • Hospital Universitario Ramon y Cajal, Madrid, Spain

  • Hospital Universitario Virgen de la Victoria, Málaga, Spain

  • Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain

  • Medical Park Bahcelievler Hastanesi, Bahçelievler, Istanbul, Turkey (Türkiye)

  • Ege Universitesi Tip Fakultesi, Bornova, İzmir, Turkey (Türkiye)

    Contact: Principal Investigator (Mahmut Tobu)
  • VM Medical Park Mersin Hospital - Ataturk, Mezitli, Mersin, Turkey (Türkiye)

    Contact: Study coordinator (Anil Tombak)
    Contact: Principal Investigator (Anil Tombak)
  • Namik Kemal Universitesi Saglik Uygulama ve Arastirma Merkezi, Altınova, Terkirdag, Turkey (Türkiye)

    Contact: Study coordinator (Seval Akapinar)
    Contact: Principal Investigator (Seval Akapinar)
  • Belfast City Hospital, Belfast, United Kingdom

  • Pilgrim Hospital, Boston, United Kingdom

    Contact: Study coordinator (Ciro Rinaldi)
    Contact: Principal Investigator (Ciro Rinaldi)
  • Imperial College Healthcare NHS Trust, London, United Kingdom

  • Milton Keynes University Hospital, Milton Keynes, United Kingdom

    Contact: Study coordinator (Magbor Akanni)
    Contact: Principal Investigator (Magbor Akanni)
  • University of Oxford - The Weatherall Institute of Molecular Medicine (WIMM), Oxford, United Kingdom

  • Southampton General Hospital, Southampton, United Kingdom

    Contact: Principal Investigator (Srinivasan Narayanan)